Clinical Trial Update: Fluzoparib in Combination With Apatinib Mesylate for Maintenance Therapy in Stage III-IV Ovarian Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating maintenance therapy with Fluzoparib in combination with Apatinib Mesylate for stage III-IV ovarian cancer; the study status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer
• Ovarian Cancer

Drugs mentioned

• Apatinib (apatinib)
• Fluzoparib (fluzoparib)

Snippet

Sponsor: Anhui Provincial Hospital | Conditions: Epithelial Ovarian Cancer, Efficacy | Phase 3 | Status: NOT_YET_RECRUITING